Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Donor bone marrow

Gajewski J, GJertson D, Cecka M et al. The impact of T cell depletion on the effects of HLA-DRBl and DQB allele matching in HLA serologically identical unrelated donor bone marrow transplantation. Biol. Blood Marrow Transplant 1997 3 76-82... [Pg.274]

Laurent, G., D. Maraninchi, E. Gluckman, J.P Vernant, J.M. Derocq, M.H. Gaspard, B. Rio, M. Michalet, J. Reiffers, F. Dreyfus, et al.. Donor bone marrow treatment with TlOl Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host disease. Bone Marrow Transplant, 1989. 4(4) 367-71. [Pg.288]

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation Weisdorf, D., Hakke, R., Blazar, B., Miller, W., McGlave, P., Ramsay, N., Kersey, J., Filipovich, A. (1991). Transplantation, 51 (6) 1197-1203. [Pg.75]

Fig. 15.2. Retroviral transduction/transplantation model of BCR-ABL induced CML. Donor mice are pretreated with 5-FU, and bone marrow cells are stimulated with cytokines in vitro. After mice were infected twice with MIG-BCR-ABL retrovirus, donor bone marrow cells are transplanted into lethally irradiated recipients for induction of CML. Fig. 15.2. Retroviral transduction/transplantation model of BCR-ABL induced CML. Donor mice are pretreated with 5-FU, and bone marrow cells are stimulated with cytokines in vitro. After mice were infected twice with MIG-BCR-ABL retrovirus, donor bone marrow cells are transplanted into lethally irradiated recipients for induction of CML.
Injection of BCR-ABL Transduced Donor Bone Marrow Cells into Lethally Irradiated Recipient Mice at Day 6... [Pg.260]

Laine, M., Ahtiainen, L., Rapola, J., Richter, J. and Jalanko, A. (2004). Bone marrow transplantation in young aspartylglucosaminuria mice Improved clearance of lysosomal storage in brain by using wild type as compared to heterozygote donors. Bone Marrow Transplant. 34, 1001-1003. [Pg.270]

Bunin N, Aplenc R, Leahey A, Magira E, Grupp S, Pierson G, Monos D. Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias. Bone Marrow Transplant 2005 35 151-8. [Pg.239]

Murata M, Harada M, Kato S, Takahashi S, Ogawa H, Okamoto S, Tsuchiya S, Sakamaki H, Akiyama Y, Kodera Y. Peripheral blood stem cell mobilization and apheresis analysis of adverse events in 94 normal donors. Bone Marrow Transplant 1999 24(10) 1065-71. [Pg.1550]

Zander AR. Stem cell mobUisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors. Bone Marrow Transplant 2002 29(9) 727-30. [Pg.1550]

LeBlanc R, Roy J, Demers C, Vu L, Cantin G. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant 1999 23(10) 991-6. [Pg.1551]

Mori T, Sato N, Watanabe R, Okamoto S, Ikeda Y. Erythema exsudativum multiforme induced by granulocyte colony-stimulating factor in an allogeneic peripheral blood stem cell donor. Bone Marrow Transplant 2000 26(2) 239 0. [Pg.1551]

Lee SJ, Kuntz KM, Horowitz MM, et al. Unrelated donor bone marrow transplantation for chronic myelogenous leukemia A decision analysis. Ann Intern Med 1997 127 1080-1088. [Pg.2524]

Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high resolution matching on outcomes of unrelated donor bone marrow transplantation HLA-C mismatching is associated with a strong adverse effect on transplant outcome. Blood 2004 104 1923— 1930. [Pg.2555]

Barker JN, Davies SM, DeEor TE, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched-unrelated donor bone marrow results of a matched-pair analysis. Blood 2001 97 2957-2961. [Pg.2556]

R4. Ruutu, T., and Goldman, J. M. A Nordic registry for volunteer marrow donors Bone Marrow Transplant. 5, 273-277 (1990). [Pg.277]

Fig. 3. Neur mice are deficient in long-term bone marrow engraflment. Sub-IethaUy irradiated Neul-null and wild-type mice were transplanted with transgenic NEUl-expressing bone marrow (BM) and analyzed 5 months after bone-marrow transplantation. To assess engraftment of the donor bone marrow, NEUl activity was measured in hematopoietic tissues liom both bone marrow-transplanted and untreated wild-type and Afeul-null mice. While all transplanted wild-type mice had successfully engrafted the donor bone marrow, 22 of the 25 transplanted JVeMi-null mice failed to engraft. Liver, yellow bars spleen, red bars BM, green bars. (See Color Plate 47.)... Fig. 3. Neur mice are deficient in long-term bone marrow engraflment. Sub-IethaUy irradiated Neul-null and wild-type mice were transplanted with transgenic NEUl-expressing bone marrow (BM) and analyzed 5 months after bone-marrow transplantation. To assess engraftment of the donor bone marrow, NEUl activity was measured in hematopoietic tissues liom both bone marrow-transplanted and untreated wild-type and Afeul-null mice. While all transplanted wild-type mice had successfully engrafted the donor bone marrow, 22 of the 25 transplanted JVeMi-null mice failed to engraft. Liver, yellow bars spleen, red bars BM, green bars. (See Color Plate 47.)...
In a typical experiment (Yamazaki, et al., in preparation), inbred mice of one H-2 type (e.g., H-2 ) were irradiated to destroy the entire hematopoietic system. Such mice would quickly succumb to infection if this system were not reconstituted with donor bone marrow and spleen cells. One group of irradiated animals was injected with these cells from a heterozygote (Fj ) donor (see Fig. 1). Another (control) group was injected with donor cells from individuals of the same H-2 type as itself. The success of the reconstitution was determined subsequently by cytotoxicity assay of lymph nodes. The question was, would the reconstituted animal produce odor more like his own genetic type or more like the donor type (an F heterozygote) In short, did cell replacement change the chemosensory identity of the subject in the direction of the donor type ... [Pg.416]

In a model of idiopathic pneumonia syndrome after bone marrow transplantation, iNOS deletional mutant mice (-/-) given donor bone marrow and spleen T cells (BMS) exhibited improved survival compared with matched BMS controls (Yang et al. 2001). Bronchoalveolar lavage fluids obtained on day 7 post bone marrow transplantation from iNOS(-/-) BMS mice contained less tumour necrosis factor-a and interferon-y, indicating that NO... [Pg.120]

Watanabe, N., Woo, S., Papageorgiou, C., Celechovsky, C., Takai, S., 2002. Fate of donor bone marrow cells in medial collateral ligament after simulated autologous transplantation. Microsc. Res. Tech. 58, 39—44. [Pg.421]

Tumorigenicity In a case report, donor bone marrow-derived stem cells produced an oral squamous cell carcinoma composed of donor cells 2 years after transplant [178 ]. [Pg.497]

Zhang H, Chen J, Que W. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in acute leukemia patients. Biol Blood Marrow Transpl 2012 18(8) 1164-73. [Pg.502]

Hu YX, Luo Y, Tan YM, Shi JM, Sheng LX, Fu HR, et al. Donor bone marrow-derived stem cells contribute to oral squamous ceU carcinoma transformation in a recipient after hematopoietic stem ceU transplantation. Stem Cells Dev January 20, 2012 21(2) 177-80. http //dx.doi. org/10.1089/scd.2011.0308. Epub 2011 Oct 18. [Pg.502]

See other pages where Donor bone marrow is mentioned: [Pg.1448]    [Pg.1451]    [Pg.483]    [Pg.1800]    [Pg.2552]    [Pg.2553]    [Pg.275]    [Pg.1619]    [Pg.274]    [Pg.274]    [Pg.398]    [Pg.186]   


SEARCH



Analysis of lymphocyte subsets in peripheral blood and bone marrow harvests from unrelated donors

Bone marrow transplantation unrelated donors

Marrow

© 2024 chempedia.info